e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determination of neurotransmitters in the brain of rats with sleep apnea syndrome
L. Xu (Tianjin, China), J. Cao (Tianjin, China)
Source:
International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Session:
Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Session type:
Thematic Poster
Number:
877
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Xu (Tianjin, China), J. Cao (Tianjin, China). Determination of neurotransmitters in the brain of rats with sleep apnea syndrome. 877
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Autonomic responses to apneas in relation with the severity of sleep apnea syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Evaluation of the executive functions of the brain in adult patients with obstructive sleep apnea syndrome
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Relation between sleep bruxism and sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 494s
Year: 2002
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Autonomic changes during obstructive and central apneas in patients with sleep apnea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Complex sleep apnoea syndrome
Source: Breathe 2013; 10: 372-380
Year: 2013
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Circadian rhythms of melatonin and cortisol in children with obstructive sleep apnea syndrome (OSA)
Source: Annual Congress 2006 - Sleep apnoea in children
Year: 2006
Pathophysiology of central sleep apnea
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
Nocturnal cardiac rhythm disturbances in obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002
Effect of N-acetylcysteine on polysomnography parameters in patients of obstructive sleep apnea with metabolic syndrome
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
The role of pharmacological treatments in sleep apnoea syndrome
Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea
Year: 2004
Altered eicosanoid generation in a rat model of sleep apnoea
Source: Eur Respir J 2003; 22: Suppl. 45, 567s
Year: 2003
Prevalence of complex sleep apnoea syndrome
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010
Visfatin levels in sleep apnea syndrome
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Childhood sleep apnea syndrome (SAHS): experience in a sleep respiratory unit
Source: Annual Congress 2006 - Sleep apnoea in children
Year: 2006
Gender difference on EEG arousal in patients with obstructive sleep apnea hypopnea syndrome
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept